1)- Anastasios Makris, Fotios Barkas, Petros P Sfikakis, Evangelos Liberopoulos, Theodosios D Filippatos, Kausik K Ray, Aris P Agouridis. Lipoprotein(a), Interleukin-6 inhibitors, and atherosclerotic cardiovascular disease: Is there an association?Atherosclerosis plus. 2023, 54: 1-6
2)- Edita Pogran, Paul M Haller, Claudia Wegberger, Maximilian Tscharre, Irena Vujasin, Christoph C Kaufmann, Petra Dick, Bernhard Jäger, Johann Wojta, Kurt Huber. The LIPL study: Postprandial lipid profile, inflammation, and platelet activity in patients with chronic coronary syndrome.Atherosclerosis plus. 2023, 54: 14-21
5)- Hadjer Namous, Maria Giuseppina Strillacci, Camila Urbano Braz, Dhanu Shanmuganayagam, Christian Krueger, Athanasios Peppas, William C Soffregen, Jess Reed, Juan F Granada, Hasan Khatib. ITGB2 is a central hub-gene associated with inflammation and early fibro-atheroma development in a swine model of atherosclerosis.Atherosclerosis plus. 2023, 54: 30-41